Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where William Wilson Turner is active.

Publication


Featured researches published by William Wilson Turner.


Bioorganic & Medicinal Chemistry Letters | 1999

The synthesis of water soluble prodrugs analogs of echinocandin B.

Michael J. Rodriguez; Vasu Vasudevan; James Andrew Jamison; Peter Stanley Borromeo; William Wilson Turner

A facile synthesis of phosphonate and phosphate ester prodrugs on the phenolic hydroxy of two echinocandin semisynthetic derivatives is reported. The water solubility and stability profiles of the ECB compounds varied with the choice of alkyl group used. In some cases, the ester prodrugs with small aliphatic side chains retained antifungal activity while enhancing water solubility.


Bioorganic & Medicinal Chemistry Letters | 2000

Syntheses and antifungal activity of pseudomycin side-chain analogues. Part 1.

James Andrew Jamison; Stuart Levy; Xicheng Sun; Doug Zeckner; William L. Current; Mark J. Zweifel; Michael J. Rodriguez; William Wilson Turner; Shu-Hui Chen

We have described herein the syntheses of three novel series of aromatic ring containing pseudomycin side-chain analogues. Preliminary biological evaluations of these analogues clearly indicate that it is possible to synthesize rigid pseudomycin side-chain analogues without compromising in vitro antifungal activity.


Tetrahedron Letters | 1998

STUDIES ON THE PHOSPHORYLATION OF LY303366

Uko Effiong Udodong; William Wilson Turner; Bret A. Astleford; Frank Brown; Marcella T. Clayton; Steven E. Dunlap; Scott Alan Frank; John L. Grutsch; Lisa Marie Hammond Lagrandeur; Daniel Edward Verral; John Arnold Werner

Abstract Phosphorylation of LY303366 ( 1 ) was studied in THF and DMF. Benzyl phosphate 2 could be prepared in excellent yield using LiOH as the base. Both 2 and the derived phosphonic acid monosodium salt 3 were prone to undergo hydrolytic dephosphorylation.


Bioorganic & Medicinal Chemistry Letters | 2015

Design and synthesis of N-[6-(Substituted Aminoethylideneamino)-2-Hydroxyindan-1-yl]arylamides as selective and potent muscarinic M1 agonists

Bin Liu; Carrie H. Croy; Stephen A. Hitchcock; Jennifer R. Allen; Zhigang Rao; David A. Evans; Mark G. Bures; David L. McKinzie; Marla Watt; G. Stuart Gregory; Marvin M. Hansen; Paul J. Hoogestraat; James Andrew Jamison; Fese M. Okha-Mokube; Robert E. Stratford; William Wilson Turner; Frank P. Bymaster; Christian C. Felder

The observation that cholinergic deafferentation of circuits projecting from forebrain basal nuclei to frontal and hippocampal circuits occurs in Alzheimers disease has led to drug-targeting of muscarinic M1 receptors to alleviate cognitive symptoms. The high homology within the acetylcholine binding domain of this family however has made receptor-selective ligand development challenging. This work presents the synthesis scheme, pharmacokinetic and structure-activity-relationship study findings for M1-selective ligand, LY593093. Pharmacologically the compound acts as an orthosteric ligand. The homology modeling work presented however will illustrate that compound binding spans from the acetylcholine pocket to the extracellular loops of the receptor, a common allosteric vestibule for the muscarinic protein family. Altogether LY593093 represents a growing class of multi-topic ligands which interact with the receptors in both the ortho- and allosteric binding sites, but which exert their activation mechanism as an orthosteric ligand.


Archive | 2005

Cyclic peptide antifungal agents and process for preparation thereof

Frederick Joseph Burkhardt; Manuel Debono; Jeffrey S. Nissen; William Wilson Turner


Archive | 1996

Cyclic peptide antifungal agents

Frederick Joseph Burkhardt; Manuel Debono; Jeffrey S. Nissen; William Wilson Turner


Antimicrobial Agents and Chemotherapy | 1998

Photoaffinity analog of the semisynthetic echinocandin LY303366: Identification of echinocandin targets in Candida albicans

Jeffrey A. Radding; Steven A. Heidler; William Wilson Turner


Archive | 2004

INDANE DERIVATES AS MUSCARINIC RECEPTOR AGONISTS

Jennifer Rebecca Allen; Stephen Andrew Hitchcock; Bin Liu; William Wilson Turner


Archive | 1996

Cyclic peptide antifungal agents and methods of making and using

Peter Stanley Borromeo; William Wilson Turner


The Journal of Antibiotics | 1998

The Synthesis and Antifungal Activity of Nitrogen Containing Hemiaminal Ethers of LY303366

James Andrew Jamison; Lisa Marie Hammond Lagrandeur; Michael J. Rodriguez; William Wilson Turner; Douglas J. Zeckner

Collaboration


Dive into the William Wilson Turner's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bin Liu

Eli Lilly and Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge